Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1891 1
1892 1
1893 1
1894 1
1901 1
1918 2
1919 1
1942 1
1944 1
1950 1
1953 1
1956 1
1958 2
1961 3
1963 4
1965 5
1967 2
1968 2
1969 3
1971 2
1972 4
1973 4
1974 4
1975 6
1976 1
1977 6
1978 4
1979 3
1980 3
1981 5
1982 5
1983 4
1984 8
1985 8
1986 10
1987 14
1988 12
1989 10
1990 8
1991 5
1992 8
1993 4
1994 3
1995 8
1996 6
1997 8
1998 2
1999 3
2000 7
2001 2
2002 2
2003 3
2004 4
2005 7
2006 8
2007 8
2008 8
2009 7
2010 9
2011 18
2012 15
2013 16
2014 27
2015 20
2016 26
2017 22
2018 25
2019 36
2020 47
2021 41
Text availability
Article attribute
Article type
Publication date

Search Results

518 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Sarimuthu
Page 1
Did you mean Charles R. marimuthu (2 results)?
COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Among authors: charles rc. Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. Cell. 2021. PMID: 33412089 Free PMC article.
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
Zohar T, Loos C, Fischinger S, Atyeo C, Wang C, Slein MD, Burke J, Yu J, Feldman J, Hauser BM, Caradonna T, Schmidt AG, Cai Y, Streeck H, Ryan ET, Barouch DH, Charles RC, Lauffenburger DA, Alter G. Zohar T, et al. Among authors: charles rc. Cell. 2020 Dec 10;183(6):1508-1519.e12. doi: 10.1016/j.cell.2020.10.052. Epub 2020 Nov 3. Cell. 2020. PMID: 33207184 Free PMC article.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, Mills R, Teng E, Kamruzzaman M, Garcia-Beltran WF, Astudillo M, Yang D, Miller TE, Oliver E, Fischinger S, Atyeo C, Iafrate AJ, Calderwood SB, Lauer SA, Yu J, Li Z, Feldman J, Hauser BM, Caradonna TM, Branda JA, Turbett SE, LaRocque RC, Mellon G, Barouch DH, Schmidt AG, Azman AS, Alter G, Ryan ET, Harris JB, Charles RC. Iyer AS, et al. Among authors: charles rc. Sci Immunol. 2020 Oct 8;5(52):eabe0367. doi: 10.1126/sciimmunol.abe0367. Sci Immunol. 2020. PMID: 33033172 Free PMC article.
SARS-CoV-2-specific ELISA development.
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G. Roy V, et al. Among authors: charles r. J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. J Immunol Methods. 2020. PMID: 32780998 Free PMC article.
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
Atyeo C, Fischinger S, Zohar T, Slein MD, Burke J, Loos C, McCulloch DJ, Newman KL, Wolf C, Yu J, Shuey K, Feldman J, Hauser BM, Caradonna T, Schmidt AG, Suscovich TJ, Linde C, Cai Y, Barouch D, Ryan ET, Charles RC, Lauffenburger D, Chu H, Alter G. Atyeo C, et al. Among authors: charles rc. Immunity. 2020 Sep 15;53(3):524-532.e4. doi: 10.1016/j.immuni.2020.07.020. Epub 2020 Jul 30. Immunity. 2020. PMID: 32783920 Free PMC article.
COVID-19 neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Among authors: charles rc. medRxiv. 2020 Oct 20:2020.10.15.20213512. doi: 10.1101/2020.10.15.20213512. Preprint. medRxiv. 2020. PMID: 33106822 Free PMC article. Updated.
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.
Miller TE, Garcia Beltran WF, Bard AZ, Gogakos T, Anahtar MN, Astudillo MG, Yang D, Thierauf J, Fisch AS, Mahowald GK, Fitzpatrick MJ, Nardi V, Feldman J, Hauser BM, Caradonna TM, Marble HD, Ritterhouse LL, Turbett SE, Batten J, Georgantas NZ, Alter G, Schmidt AG, Harris JB, Gelfand JA, Poznansky MC, Bernstein BE, Louis DN, Dighe A, Charles RC, Ryan ET, Branda JA, Pierce VM, Murali MR, Iafrate AJ, Rosenberg ES, Lennerz JK. Miller TE, et al. Among authors: charles rc. FASEB J. 2020 Oct;34(10):13877-13884. doi: 10.1096/fj.202001700RR. Epub 2020 Aug 28. FASEB J. 2020. PMID: 32856766 Free PMC article. Clinical Trial.
518 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page